IKAROS Family Zinc Finger 3 (Aiolos) (IKZF3) Peptide
-
- Target See all IKZF3 products
- IKZF3 (IKAROS Family Zinc Finger 3 (Aiolos) (IKZF3))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- LDYVMFTIHM GCHGFRDPFE CNMCGYRSHD RYEFSSHIAR GEHRALLK
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of IKZF3 antibody,
Alternative Names: IKZF3 control peptide, IKZF3 antibody Blocking Peptide, Anti-IKZF3 Blocking Peptide, IKAROS family zinc finger 3, Aiolos Blocking Peptide, AIOLOS Blocking Peptide, ZNFN1A3 Blocking Peptide, IKZF3, IKZF-3, IKZF 3, IKZF-3 Blocking Peptide, IKZF 3 Blocking Peptide - Purification
- Immunoaffinity chromatography.
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- IKZF3 (IKAROS Family Zinc Finger 3 (Aiolos) (IKZF3))
- Synonyms
- AIO Peptide, AIOLOS Peptide, ZNFN1A3 Peptide, aio Peptide, aiolos Peptide, znfn1a3 Peptide, IKZF3 Peptide, 5830411O07Rik Peptide, Aiolos Peptide, Zfpn1a3 Peptide, Znfn1a3 Peptide, IKAROS family zinc finger 3 Peptide, IKAROS family zinc finger 3 L homeolog Peptide, IKZF3 Peptide, ikzf3.L Peptide, Ikzf3 Peptide
- Background
- IKZF3 is a member of the Ikaros family of zinc-finger proteins. Three members of this protein family (Ikaros, Aiolos and Helios) are hematopoetic-specific transcription factors involved in the regulation of lymphocyte development. This gene product is a transcription factor that is important in the regulation of B lymphocyte proliferation and differentiation. Both Ikaros and Aiolos can participate in chromatin remodeling. Regulation of gene expression in B lymphocytes by Aiolos is complex as it appears to require the sequential formation of Ikaros homodimers, Ikaros/Aiolos heterodimers, and Aiolos homodimers. At least six alternative transcripts encoding different isoforms have been described.
- Molecular Weight
- 58 kDa
-